{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:34:06Z","timestamp":1791297246251,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.biopsych.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T04:18:08Z","timestamp":1344485888000},"page":"414-421","source":"Crossref","is-referenced-by-count":49,"title":["Association of Stroke with the Receptor-Binding Profiles of Antipsychotics\u2014A Case-Crossover Study"],"prefix":"10.1016","volume":"73","author":[{"given":"Chi-Shin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Shur-Fen","family":"Gau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ju","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.07.006_bib1","series-title":"The Atlas of Heart Disease and Stroke","year":"2007"},{"key":"10.1016\/j.biopsych.2012.07.006_bib2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11524-007-9195-1","article-title":"Urbanization and stroke prevalence in Taiwan: Analysis of a nationwide survey","volume":"84","author":"Lin","year":"2007","journal-title":"J Urban Health"},{"key":"10.1016\/j.biopsych.2012.07.006_bib3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/01.STR.23.9.1237","article-title":"Incidence of stroke in Taiwan","volume":"23","author":"Hu","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.biopsych.2012.07.006_bib4","series-title":"Standardize Death Rates from Leading Causes of Death","year":"2007"},{"key":"10.1016\/j.biopsych.2012.07.006_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.1367","article-title":"Trends in psychotropic medication use among U.S. adults","volume":"16","author":"Paulose-Ram","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.biopsych.2012.07.006_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/appi.ps.58.4.554","article-title":"Trends in the use of psychotropic drugs in Taiwan: A population-based national health insurance study, 1997-2004","volume":"58","author":"Chien","year":"2007","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.biopsych.2012.07.006_bib7","first-page":"1269","article-title":"Risperidone (Risperdal): Increased rate of cerebrovascular events in dementia trials","volume":"167","author":"Wooltorton","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.biopsych.2012.07.006_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ajp.161.6.1113","article-title":"Atypical antipsychotics and risk of cerebrovascular accidents","volume":"161","author":"Herrmann","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1533317510390351","article-title":"Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: A literature review of evidence","volume":"26","author":"Mittal","year":"2011","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.biopsych.2012.07.006_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11319120-000000000-00000","article-title":"Cerebrovascular accidents in elderly people treated with antipsychotic drugs: A systematic review","volume":"33","author":"Sacchetti","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.biopsych.2012.07.006_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00023210-200519020-00001","article-title":"Do atypical antipsychotics cause stroke?","volume":"19","author":"Herrmann","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2012.07.006_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4088\/JCP.v67n0610","article-title":"A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia","volume":"67","author":"Kryzhanovskaya","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clineuro.2005.03.013","article-title":"Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone","volume":"107","author":"De Deyn","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.biopsych.2012.07.006_bib15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","article-title":"Why we need observational studies to evaluate the effectiveness of health care","volume":"312","author":"Black","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2012.07.006_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.297.3.314","article-title":"Estimating treatment effects using observational data","volume":"297","author":"D'Agostino","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2012.07.006_bib17","doi-asserted-by":"crossref","first-page":"a1227","DOI":"10.1136\/bmj.a1227","article-title":"Exposure to antipsychotics and risk of stroke: Self controlled case series study","volume":"337","author":"Douglas","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2012.07.006_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/0269881108093583","article-title":"Risk of cerebrovascular events in elderly users of antipsychotics","volume":"23","author":"Kleijer","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.jcp.0000178414.14685.c4","article-title":"Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly","volume":"25","author":"Percudani","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0269881107080792","article-title":"Risk of stroke with typical and atypical anti-psychotics: A retrospective cohort study including unexposed subjects","volume":"22","author":"Sacchetti","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1532-5415.2011.03479.x","article-title":"Risk of cerebrovascular accident associated with use of antipsychotics: Population-based case-control study","volume":"59","author":"Laredo","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.biopsych.2012.07.006_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/jcp.0b013e31815a2531","article-title":"Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users","volume":"27","author":"Barnett","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/gps.2347","article-title":"Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: A hospital-based, retrospective, cohort study","volume":"25","author":"Chan","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4088\/JCP.v66n0901","article-title":"Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics","volume":"66","author":"Liperoti","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/0269881109103202","article-title":"Timing of stroke in elderly people exposed to typical and atypical antipsychotics: A replication cohort study after the paper of Kleijer, et al","volume":"24","author":"Sacchetti","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"suppl 10","key":"10.1016\/j.biopsych.2012.07.006_bib26","first-page":"5","article-title":"Receptor pharmacology of neuroleptics: Relation to clinical effects","volume":"60","author":"Richelson","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2004.03.004","article-title":"Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: A novel approach for CNS drug discovery","volume":"102","author":"Roth","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2012.07.006_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.07.006_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0269881105056524","article-title":"Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia","volume":"19","author":"Layton","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1041610205002280","article-title":"Risperidone treatment in elderly patients with dementia: Relative risk of cerebrovascular events versus other antipsychotics","volume":"17","author":"Finkel","year":"2005","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.biopsych.2012.07.006_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2012.07.006_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: A method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"suppl 3","key":"10.1016\/j.biopsych.2012.07.006_bib33","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J","article-title":"Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research","volume":"6","author":"Schneeweiss","year":"1997","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.biopsych.2012.07.006_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1176\/appi.ajp.2010.10071064","article-title":"Association of cerebrovascular events with antidepressant use: A case-crossover study","volume":"168","author":"Wu","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib35","series-title":"Guidelines for ATC Classification and DDD Assignment","year":"2009"},{"key":"10.1016\/j.biopsych.2012.07.006_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.006_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0031-6997(24)01495-9","article-title":"Vascular adrenoceptors: An update","volume":"53","author":"Guimaraes","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2012.07.006_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00006842-200007000-00014","article-title":"Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans","volume":"62","author":"Cameron","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1016\/j.biopsych.2012.07.006_bib40","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00004647-199907000-00010","article-title":"Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: Identification and cellular localization","volume":"19","author":"Elhusseiny","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2012.07.006_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2012.07.006_bib42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","article-title":"Subcortical ischaemic vascular dementia","volume":"1","author":"Roman","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2012.07.006_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2007.12.485","article-title":"An increased risk of stroke among young schizophrenia patients","volume":"101","author":"Lin","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.07.006_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.biopsych.2012.07.006_bib45","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/hs1201.100209","article-title":"Epidemiology of ischemic stroke subtypes according to TOAST criteria: Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study","volume":"32","author":"Kolominsky-Rabas","year":"2001","journal-title":"Stroke"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312006002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312006002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:27:54Z","timestamp":1743964074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312006002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0006322312006002"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.07.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}